Literature DB >> 625309

Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

J G Bartlett, T W Chang, M Gurwith, S L Gorbach, A B Onderdonk.   

Abstract

A substance producing cytotoxicity in tissue culture was detected in stool specimens from all of four patients with pseudomembranous colitis due to antibiotics and in one of 54 with antibiotic-associated diarrhea. These stools also caused enterocolitis when injected intracecally into hamsters. On each occasion, cytotoxicity in tissue culture and enterocolitis in hamsters were neutralized by pretreatment with gas-gangrene antitoxin. The toxicity in both tissue cultures and hamsters could be reproduced with broth cultures of clostridia strains isolated from four of the five stools. These results suggest that toxin-producing clostridia are responsible for antibiotic-associated pseudomembranous colitis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 625309     DOI: 10.1056/NEJM197803092981003

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  333 in total

1.  Fatal ulcerative panenteritis following colectomy in a patient with ulcerative colitis.

Authors:  V Annese; N Caruso; M Bisceglia; G Lombardi; R Clemente; G Modola; B Tardio; M R Villani; A Andriulli
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

2.  Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization.

Authors:  A Tasteyre; M C Barc; A Collignon; H Boureau; T Karjalainen
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 3.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

4.  Managing antibiotic associated diarrhoea.

Authors:  Frédéric Barbut; Jean Luc Meynard
Journal:  BMJ       Date:  2002-06-08

5.  Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A.

Authors:  S M Frey; T D Wilkins
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

6.  Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.

Authors:  J A Bosso; R A Prince
Journal:  Tex Heart Inst J       Date:  1990

Review 7.  Clostridium difficile infection: management strategies for a difficult disease.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Therap Adv Gastroenterol       Date:  2014-03       Impact factor: 4.409

8.  Bacitracin therapy in antibiotic-associated pseudomembranous colitis.

Authors:  F J Tedesco
Journal:  Dig Dis Sci       Date:  1980-10       Impact factor: 3.199

9.  Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.

Authors:  Mi Na Kim; Seong-Joon Koh; Jung Mogg Kim; Jong Pil Im; Hyun Chae Jung; Joo Sung Kim
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy.

Authors:  S S Johal; J Hammond; K Solomon; P D James; Y R Mahida
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.